global glp-1 obesity drug market size forecast 2030 Beyond GLP-1Rs: emerging targets poised to gain share of Obesity GLP-1 Market Size to

GLP-1 Action The major target tissues for GLP-1 are the pancreatic islet cells but it also has actions on gastrointestinal secretion and motility of the stomach and exocrine pancreas

Heart attacks and strokes are down 20%

Despite the cardioprotective effects of semaglutide 2.4mg, whether the combination of GLP-1 RA with other entero-pancreatic hormones will also improve cardiovascular outcomes in people with obesity and/or T2D needs to be established

[DOI] [PubMed] [Google Scholar] 5.Unger R.H., Orci L

It is the same medication, but instead of a weekly injection, it is taken as a once daily tablet

The Mounjaro prices which were provided by Aspen include VAT but not dispensing fees